StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/306% below fair value
$13.86+0.31 (+2.29%)

Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –

Integra LifeSciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Integra LifeSciences's price to sales ratio was 0.7× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.4× to 3.7×, with a median of 1.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×+0.1
2025Dec 31, 20250.6×−0.5
2024Dec 31, 20241.1×−1.2
2023Dec 29, 20232.3×−0.7
2022Dec 30, 20223.0×−0.7
2021Dec 31, 20213.7×−0.3
2020Dec 31, 20204.0×+0.7
2019Dec 31, 20193.3×+0.8
2018Dec 31, 20182.5×−1.0
2017Dec 29, 20173.5×+0.0
2016Dec 30, 20163.5×+0.8
2015Dec 31, 20152.7×+0.7
2014Dec 31, 20142.0×+0.5
2013Dec 31, 20131.5×+0.2
2012Dec 31, 20121.2×+0.2
2011Dec 30, 20111.1×−0.7
2010Dec 31, 20101.8×+0.3
2009Dec 31, 20091.4×–

More Integra LifeSciences figures

See a number that looks wrong?